Respiratory Disease Vaccine Market Research Report by Infection (Influenza Virus, Pertussis, Streptococcus Pneumoniae, and Tuberculosis), by Type (Bacterial Vaccine, Combination Vaccine, and Viral Vaccine), by Age Group - Global Forecast to 2025 - Cumulative Impact of COVID-19
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Respiratory Disease Vaccine Market is expected to grow from USD 19,923.38 Million in 2020 to USD 25,236.13 Million by the end of 2025.
2. The Global Respiratory Disease Vaccine Market is expected to grow from EUR 17,469.20 Million in 2020 to EUR 22,127.51 Million by the end of 2025.
3. The Global Respiratory Disease Vaccine Market is expected to grow from GBP 15,530.16 Million in 2020 to GBP 19,671.41 Million by the end of 2025.
4. The Global Respiratory Disease Vaccine Market is expected to grow from JPY 2,126,330.52 Million in 2020 to JPY 2,693,334.55 Million by the end of 2025.
5. The Global Respiratory Disease Vaccine Market is expected to grow from AUD 28,931.41 Million in 2020 to AUD 36,646.21 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Respiratory Disease Vaccine to forecast the revenues and analyze the trends in each of the following sub-markets:
'The Streptococcus Pneumoniae is projected to witness the highest growth during the forecast period'
Based on Infection, the Respiratory Disease Vaccine Market studied across Influenza Virus, Pertussis, Streptococcus Pneumoniae, and Tuberculosis. The Influenza Virus commanded the largest size in the Respiratory Disease Vaccine Market in 2020. On the other hand, the Streptococcus Pneumoniae is expected to grow at the fastest CAGR during the forecast period.
'The Combination Vaccine is projected to witness the highest growth during the forecast period'
Based on Type, the Respiratory Disease Vaccine Market studied across Bacterial Vaccine, Combination Vaccine, and Viral Vaccine. The Viral Vaccine commanded the largest size in the Respiratory Disease Vaccine Market in 2020. On the other hand, the Combination Vaccine is expected to grow at the fastest CAGR during the forecast period.
'The Adult Vaccination is projected to witness the highest growth during the forecast period'
Based on Age Group, the Respiratory Disease Vaccine Market studied across Adolescent Vaccination, Adult Vaccination, and Infant Vaccination. The Infant Vaccination commanded the largest size in the Respiratory Disease Vaccine Market in 2020. On the other hand, the Adult Vaccination is expected to grow at the fastest CAGR during the forecast period.
'The Asia-Pacific is projected to witness the highest growth during the forecast period'
Based on Geography, the Respiratory Disease Vaccine Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Americas commanded the largest size in the Respiratory Disease Vaccine Market in 2020. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Respiratory Disease Vaccine Market including AstraZeneca, Bavarian Nordic, Bayer AG, Bio Farma, Dynavax Technologies Corporation, Emergent BioSolutions, Inc., GlaxoSmithKline plc, Merck & Co., Inc., Pfizer Inc., Sanofi S.A., Seqirus USA Inc., and Serum institute of India Private Limited.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Respiratory Disease Vaccine Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Respiratory Disease Vaccine Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Respiratory Disease Vaccine Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Respiratory Disease Vaccine Market?
4. What is the competitive strategic window for opportunities in the Global Respiratory Disease Vaccine Market?
5. What are the technology trends and regulatory frameworks in the Global Respiratory Disease Vaccine Market?
6. What are the modes and strategic moves considered suitable for entering the Global Respiratory Disease Vaccine Market?
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Respiratory Disease Vaccine Market is expected to grow from USD 19,923.38 Million in 2020 to USD 25,236.13 Million by the end of 2025.
2. The Global Respiratory Disease Vaccine Market is expected to grow from EUR 17,469.20 Million in 2020 to EUR 22,127.51 Million by the end of 2025.
3. The Global Respiratory Disease Vaccine Market is expected to grow from GBP 15,530.16 Million in 2020 to GBP 19,671.41 Million by the end of 2025.
4. The Global Respiratory Disease Vaccine Market is expected to grow from JPY 2,126,330.52 Million in 2020 to JPY 2,693,334.55 Million by the end of 2025.
5. The Global Respiratory Disease Vaccine Market is expected to grow from AUD 28,931.41 Million in 2020 to AUD 36,646.21 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Respiratory Disease Vaccine to forecast the revenues and analyze the trends in each of the following sub-markets:
'The Streptococcus Pneumoniae is projected to witness the highest growth during the forecast period'
Based on Infection, the Respiratory Disease Vaccine Market studied across Influenza Virus, Pertussis, Streptococcus Pneumoniae, and Tuberculosis. The Influenza Virus commanded the largest size in the Respiratory Disease Vaccine Market in 2020. On the other hand, the Streptococcus Pneumoniae is expected to grow at the fastest CAGR during the forecast period.
'The Combination Vaccine is projected to witness the highest growth during the forecast period'
Based on Type, the Respiratory Disease Vaccine Market studied across Bacterial Vaccine, Combination Vaccine, and Viral Vaccine. The Viral Vaccine commanded the largest size in the Respiratory Disease Vaccine Market in 2020. On the other hand, the Combination Vaccine is expected to grow at the fastest CAGR during the forecast period.
'The Adult Vaccination is projected to witness the highest growth during the forecast period'
Based on Age Group, the Respiratory Disease Vaccine Market studied across Adolescent Vaccination, Adult Vaccination, and Infant Vaccination. The Infant Vaccination commanded the largest size in the Respiratory Disease Vaccine Market in 2020. On the other hand, the Adult Vaccination is expected to grow at the fastest CAGR during the forecast period.
'The Asia-Pacific is projected to witness the highest growth during the forecast period'
Based on Geography, the Respiratory Disease Vaccine Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Americas commanded the largest size in the Respiratory Disease Vaccine Market in 2020. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Respiratory Disease Vaccine Market including AstraZeneca, Bavarian Nordic, Bayer AG, Bio Farma, Dynavax Technologies Corporation, Emergent BioSolutions, Inc., GlaxoSmithKline plc, Merck & Co., Inc., Pfizer Inc., Sanofi S.A., Seqirus USA Inc., and Serum institute of India Private Limited.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Respiratory Disease Vaccine Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Respiratory Disease Vaccine Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Respiratory Disease Vaccine Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Respiratory Disease Vaccine Market?
4. What is the competitive strategic window for opportunities in the Global Respiratory Disease Vaccine Market?
5. What are the technology trends and regulatory frameworks in the Global Respiratory Disease Vaccine Market?
6. What are the modes and strategic moves considered suitable for entering the Global Respiratory Disease Vaccine Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Infection Outlook
3.4. Age Group Outlook
3.5. Type Outlook
3.6. Geography Outlook
3.7. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of respiratory disorders
5.1.1.2. Clinical trials and vaccines developments in pipeline
5.1.1.3. Government initiatives supporting respiratory health
5.1.2. Restraints
5.1.2.1. Lack of inadequate delivery infrastructure & limited awareness
5.1.3. Opportunities
5.1.3.1. Increasing R&D expenditure by leading companies
5.1.3.2. Increase vaccine availability through reselling collaborations
5.1.4. Challenges
5.1.4.1. Consumer trust & confidence in respiratory disease vaccination
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL RESPIRATORY DISEASE VACCINE MARKET, BY INFECTION
6.1. Introduction
6.2. Influenza Virus
6.3. Pertussis
6.4. Streptococcus Pneumoniae
6.5. Tuberculosis
7. GLOBAL RESPIRATORY DISEASE VACCINE MARKET, BY TYPE
7.1. Introduction
7.2. Bacterial Vaccine
7.3. Combination Vaccine
7.4. Viral Vaccine
8. GLOBAL RESPIRATORY DISEASE VACCINE MARKET, BY AGE GROUP
8.1. Introduction
8.2. Adolescent Vaccination
8.3. Adult Vaccination
8.4. Infant Vaccination
9. AMERICAS RESPIRATORY DISEASE VACCINE MARKET
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. ASIA-PACIFIC RESPIRATORY DISEASE VACCINE MARKET
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. South Korea
10.10. Thailand
11. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. COMPETITIVE LANDSCAPE
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis
12.4. Competitor SWOT Analysis
12.5. Competitive Scenario
12.5.1. Merger & Acquisition
12.5.2. Agreement, Collaboration, & Partnership
12.5.3. New Product Launch & Enhancement
12.5.4. Investment & Funding
12.5.5. Award, Recognition, & Expansion
13. COMPANY USABILITY PROFILES
13.1. AstraZeneca
13.2. Bavarian Nordic
13.3. Bayer AG
13.4. Bio Farma
13.5. Dynavax Technologies Corporation
13.6. Emergent BioSolutions, Inc.
13.7. GlaxoSmithKline plc
13.8. Merck & Co., Inc.
13.9. Pfizer Inc.
13.10. Sanofi S.A.
13.11. Seqirus USA Inc.
13.12. Serum institute of India Private Limited
14. APPENDIX
14.1. Discussion Guide
14.2. License & Pricing
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Infection Outlook
3.4. Age Group Outlook
3.5. Type Outlook
3.6. Geography Outlook
3.7. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of respiratory disorders
5.1.1.2. Clinical trials and vaccines developments in pipeline
5.1.1.3. Government initiatives supporting respiratory health
5.1.2. Restraints
5.1.2.1. Lack of inadequate delivery infrastructure & limited awareness
5.1.3. Opportunities
5.1.3.1. Increasing R&D expenditure by leading companies
5.1.3.2. Increase vaccine availability through reselling collaborations
5.1.4. Challenges
5.1.4.1. Consumer trust & confidence in respiratory disease vaccination
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL RESPIRATORY DISEASE VACCINE MARKET, BY INFECTION
6.1. Introduction
6.2. Influenza Virus
6.3. Pertussis
6.4. Streptococcus Pneumoniae
6.5. Tuberculosis
7. GLOBAL RESPIRATORY DISEASE VACCINE MARKET, BY TYPE
7.1. Introduction
7.2. Bacterial Vaccine
7.3. Combination Vaccine
7.4. Viral Vaccine
8. GLOBAL RESPIRATORY DISEASE VACCINE MARKET, BY AGE GROUP
8.1. Introduction
8.2. Adolescent Vaccination
8.3. Adult Vaccination
8.4. Infant Vaccination
9. AMERICAS RESPIRATORY DISEASE VACCINE MARKET
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. ASIA-PACIFIC RESPIRATORY DISEASE VACCINE MARKET
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. South Korea
10.10. Thailand
11. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. COMPETITIVE LANDSCAPE
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis
12.4. Competitor SWOT Analysis
12.5. Competitive Scenario
12.5.1. Merger & Acquisition
12.5.2. Agreement, Collaboration, & Partnership
12.5.3. New Product Launch & Enhancement
12.5.4. Investment & Funding
12.5.5. Award, Recognition, & Expansion
13. COMPANY USABILITY PROFILES
13.1. AstraZeneca
13.2. Bavarian Nordic
13.3. Bayer AG
13.4. Bio Farma
13.5. Dynavax Technologies Corporation
13.6. Emergent BioSolutions, Inc.
13.7. GlaxoSmithKline plc
13.8. Merck & Co., Inc.
13.9. Pfizer Inc.
13.10. Sanofi S.A.
13.11. Seqirus USA Inc.
13.12. Serum institute of India Private Limited
14. APPENDIX
14.1. Discussion Guide
14.2. License & Pricing
LIST OF TABLES
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFLUENZA VIRUS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY PERTUSSIS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY STREPTOCOCCUS PNEUMONIAE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TUBERCULOSIS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY BACTERIAL VACCINE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY COMBINATION VACCINE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VIRAL VACCINE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADOLESCENT VACCINATION, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADULT VACCINATION, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFANT VACCINATION, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. ARGENTINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. ARGENTINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. ARGENTINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. BRAZIL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. BRAZIL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. BRAZIL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. CANADA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. CANADA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. CANADA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. MEXICO RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. MEXICO RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. MEXICO RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. UNITED STATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. UNITED STATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. UNITED STATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. ASIA-PACIFIC RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. ASIA-PACIFIC RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. ASIA-PACIFIC RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. ASIA-PACIFIC RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. AUSTRALIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. AUSTRALIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. AUSTRALIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. CHINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. CHINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. CHINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. INDIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. INDIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. INDIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. INDONESIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. INDONESIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. INDONESIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. JAPAN RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. JAPAN RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. JAPAN RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. MALAYSIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. MALAYSIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. MALAYSIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. PHILIPPINES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. PHILIPPINES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. PHILIPPINES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. SOUTH KOREA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. SOUTH KOREA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. SOUTH KOREA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. THAILAND RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. THAILAND RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. THAILAND RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. FRANCE RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. FRANCE RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. FRANCE RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. GERMANY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. GERMANY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. GERMANY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. ITALY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. ITALY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. ITALY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. NETHERLANDS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. NETHERLANDS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. NETHERLANDS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. QATAR RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. QATAR RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. QATAR RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. RUSSIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. RUSSIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. RUSSIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. SAUDI ARABIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. SAUDI ARABIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. SAUDI ARABIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. SOUTH AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. SOUTH AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. SOUTH AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. SPAIN RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. SPAIN RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. SPAIN RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. UNITED ARAB EMIRATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. UNITED ARAB EMIRATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. UNITED ARAB EMIRATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. UNITED KINGDOM RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. UNITED KINGDOM RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. UNITED KINGDOM RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. GLOBAL RESPIRATORY DISEASE VACCINE MARKET: SCORES
TABLE 105. GLOBAL RESPIRATORY DISEASE VACCINE MARKET: BUSINESS STRATEGY
TABLE 106. GLOBAL RESPIRATORY DISEASE VACCINE MARKET: PRODUCT SATISFACTION
TABLE 107. GLOBAL RESPIRATORY DISEASE VACCINE MARKET: RANKING
TABLE 108. GLOBAL RESPIRATORY DISEASE VACCINE MARKET: MERGER & ACQUISITION
TABLE 109. GLOBAL RESPIRATORY DISEASE VACCINE MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 110. GLOBAL RESPIRATORY DISEASE VACCINE MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 111. GLOBAL RESPIRATORY DISEASE VACCINE MARKET: INVESTMENT & FUNDING
TABLE 112. GLOBAL RESPIRATORY DISEASE VACCINE MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 113. GLOBAL RESPIRATORY DISEASE VACCINE MARKET: LICENSE & PRICING
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFLUENZA VIRUS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY PERTUSSIS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY STREPTOCOCCUS PNEUMONIAE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TUBERCULOSIS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY BACTERIAL VACCINE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY COMBINATION VACCINE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VIRAL VACCINE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADOLESCENT VACCINATION, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADULT VACCINATION, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFANT VACCINATION, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. ARGENTINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. ARGENTINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. ARGENTINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. BRAZIL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. BRAZIL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. BRAZIL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. CANADA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. CANADA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. CANADA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. MEXICO RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. MEXICO RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. MEXICO RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. UNITED STATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. UNITED STATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. UNITED STATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. ASIA-PACIFIC RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. ASIA-PACIFIC RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. ASIA-PACIFIC RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. ASIA-PACIFIC RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. AUSTRALIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. AUSTRALIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. AUSTRALIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. CHINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. CHINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. CHINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. INDIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. INDIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. INDIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. INDONESIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. INDONESIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. INDONESIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. JAPAN RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. JAPAN RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. JAPAN RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. MALAYSIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. MALAYSIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. MALAYSIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. PHILIPPINES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. PHILIPPINES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. PHILIPPINES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. SOUTH KOREA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. SOUTH KOREA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. SOUTH KOREA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. THAILAND RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. THAILAND RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. THAILAND RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. FRANCE RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. FRANCE RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. FRANCE RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. GERMANY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. GERMANY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. GERMANY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. ITALY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. ITALY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. ITALY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. NETHERLANDS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. NETHERLANDS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. NETHERLANDS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. QATAR RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. QATAR RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. QATAR RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. RUSSIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. RUSSIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. RUSSIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. SAUDI ARABIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. SAUDI ARABIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. SAUDI ARABIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. SOUTH AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. SOUTH AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. SOUTH AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. SPAIN RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. SPAIN RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. SPAIN RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. UNITED ARAB EMIRATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. UNITED ARAB EMIRATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. UNITED ARAB EMIRATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. UNITED KINGDOM RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. UNITED KINGDOM RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. UNITED KINGDOM RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. GLOBAL RESPIRATORY DISEASE VACCINE MARKET: SCORES
TABLE 105. GLOBAL RESPIRATORY DISEASE VACCINE MARKET: BUSINESS STRATEGY
TABLE 106. GLOBAL RESPIRATORY DISEASE VACCINE MARKET: PRODUCT SATISFACTION
TABLE 107. GLOBAL RESPIRATORY DISEASE VACCINE MARKET: RANKING
TABLE 108. GLOBAL RESPIRATORY DISEASE VACCINE MARKET: MERGER & ACQUISITION
TABLE 109. GLOBAL RESPIRATORY DISEASE VACCINE MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 110. GLOBAL RESPIRATORY DISEASE VACCINE MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 111. GLOBAL RESPIRATORY DISEASE VACCINE MARKET: INVESTMENT & FUNDING
TABLE 112. GLOBAL RESPIRATORY DISEASE VACCINE MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 113. GLOBAL RESPIRATORY DISEASE VACCINE MARKET: LICENSE & PRICING
LIST OF FIGURES
FIGURE 1. GLOBAL RESPIRATORY DISEASE VACCINE MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL RESPIRATORY DISEASE VACCINE MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2020 (USD MILLION)
FIGURE 5. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2020 (USD MILLION)
FIGURE 6. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2020 (USD MILLION)
FIGURE 7. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 8. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 9. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 10. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 12. GLOBAL RESPIRATORY DISEASE VACCINE MARKET: MARKET DYNAMICS
FIGURE 13. GLOBAL RESPIRATORY DISEASE VACCINE MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 14. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2020 VS 2025 (%)
FIGURE 15. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2020 VS 2025 (USD MILLION)
FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2025
FIGURE 17. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFLUENZA VIRUS, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY PERTUSSIS, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY STREPTOCOCCUS PNEUMONIAE, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TUBERCULOSIS, 2020 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2020 VS 2025 (%)
FIGURE 22. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 23. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2025
FIGURE 24. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY BACTERIAL VACCINE, 2020 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY COMBINATION VACCINE, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VIRAL VACCINE, 2020 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2020 VS 2025 (%)
FIGURE 28. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2020 VS 2025 (USD MILLION)
FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2025
FIGURE 30. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADOLESCENT VACCINATION, 2020 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADULT VACCINATION, 2020 VS 2025 (USD MILLION)
FIGURE 32. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFANT VACCINATION, 2020 VS 2025 (USD MILLION)
FIGURE 33. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 34. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 35. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 36. ARGENTINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 37. BRAZIL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 38. CANADA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 39. MEXICO RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 40. UNITED STATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 41. ASIA-PACIFIC RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 42. ASIA-PACIFIC RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 43. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 44. AUSTRALIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. CHINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. INDIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. INDONESIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. JAPAN RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 49. MALAYSIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. PHILIPPINES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. SOUTH KOREA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. THAILAND RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 54. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 55. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 56. FRANCE RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. GERMANY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. ITALY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. NETHERLANDS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. QATAR RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 61. RUSSIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 62. SAUDI ARABIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 63. SOUTH AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. SPAIN RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 65. UNITED ARAB EMIRATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 66. UNITED KINGDOM RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 67. GLOBAL RESPIRATORY DISEASE VACCINE MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 68. GLOBAL RESPIRATORY DISEASE VACCINE MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 69. GLOBAL RESPIRATORY DISEASE VACCINE MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 70. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL RESPIRATORY DISEASE VACCINE MARKET, BY TYPE
FIGURE 1. GLOBAL RESPIRATORY DISEASE VACCINE MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL RESPIRATORY DISEASE VACCINE MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2020 (USD MILLION)
FIGURE 5. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2020 (USD MILLION)
FIGURE 6. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2020 (USD MILLION)
FIGURE 7. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 8. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 9. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 10. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 12. GLOBAL RESPIRATORY DISEASE VACCINE MARKET: MARKET DYNAMICS
FIGURE 13. GLOBAL RESPIRATORY DISEASE VACCINE MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 14. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2020 VS 2025 (%)
FIGURE 15. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2020 VS 2025 (USD MILLION)
FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2025
FIGURE 17. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFLUENZA VIRUS, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY PERTUSSIS, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY STREPTOCOCCUS PNEUMONIAE, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TUBERCULOSIS, 2020 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2020 VS 2025 (%)
FIGURE 22. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 23. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2025
FIGURE 24. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY BACTERIAL VACCINE, 2020 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY COMBINATION VACCINE, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VIRAL VACCINE, 2020 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2020 VS 2025 (%)
FIGURE 28. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2020 VS 2025 (USD MILLION)
FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2025
FIGURE 30. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADOLESCENT VACCINATION, 2020 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADULT VACCINATION, 2020 VS 2025 (USD MILLION)
FIGURE 32. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFANT VACCINATION, 2020 VS 2025 (USD MILLION)
FIGURE 33. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 34. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 35. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 36. ARGENTINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 37. BRAZIL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 38. CANADA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 39. MEXICO RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 40. UNITED STATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 41. ASIA-PACIFIC RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 42. ASIA-PACIFIC RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 43. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 44. AUSTRALIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. CHINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. INDIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. INDONESIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. JAPAN RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 49. MALAYSIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. PHILIPPINES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. SOUTH KOREA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. THAILAND RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 54. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 55. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 56. FRANCE RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. GERMANY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. ITALY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. NETHERLANDS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. QATAR RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 61. RUSSIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 62. SAUDI ARABIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 63. SOUTH AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. SPAIN RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 65. UNITED ARAB EMIRATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 66. UNITED KINGDOM RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 67. GLOBAL RESPIRATORY DISEASE VACCINE MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 68. GLOBAL RESPIRATORY DISEASE VACCINE MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 69. GLOBAL RESPIRATORY DISEASE VACCINE MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 70. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL RESPIRATORY DISEASE VACCINE MARKET, BY TYPE
